bioma glp-1 to the rescue #weightloss #glp1 #journey Prebiotics, Probiotics and Postbiotics for

FDA approvals are increasing Medicare coverage, but it is still a long way from covering all recipients with obesity

The Food and Drug Administration (FDA) granted expedited approval to orforglipron, a GLP-1 drug that works similarly to widely used injectable treatments by mimicking a natural hormone that helps regulate appetite and feelings of fullness

These findings suggest potential synergistic effects, which are consistent with previous studies highlighting the antioxidant synergy between vitamin C and glutathione (25)

It is worth being honest about the evidence: fat-dissolving injections like this are not FDA approved and the clinical research base is limited